Ver proposes a novel therapeutic approach to correcting strabismus, otherwise known as cross-eyedness. Due to the inability of both eyes to naturally gaze at a single focal point, individuals with strabismus suffer from double vision and a lack of depth perception. Current treatment options include eye-patch therapy and surgery. Both of these options are painful and not completely effective. Ver instead seeks to combine our created image-warping software with the power of existing virtual reality technology to correct strabismus overtime.
Our product design involves the commercially-available Vive Pro Eye virtual reality headset. With the eye tracking capabilities of this hardware and its external cameras, we will first gather the image that the dominant, unaffected eye is focused on (Figure 1). Our software will take the image and warp it first to the correct plane of the non-dominant, affected eye and then back onto the screen of the headset. This will restore binocular vision to the individual. In a therapeutic setting, the corrective factor of the software will slowly be turned down as therapy progresses to allow for the affected eye to adjust and gain strength overtime. Through our research, this process should be more effective and less painful for strabismus patients.
Ver is currently awaiting IRB approval for human testing in the spring. Our initial in-silico testing suite demonstrates the first iteration of our software performs better than a simulated strabismus patient, providing us with a successful proof of concept to move forward. Ver is funded in part by the Berkman Opportunity Fund, which aided us in purchasing the Vive Pro Eye for the hardware component of our project. Moving forward, our team will be porting the software to the Vive for testing as the software is optimized for decreased error.